Olema Oncology announced the appointment of Sean P. Bohen, M.D., Ph.D., as President. Dr. Bohen was most recently Executive Vice President of Global Medicines Development and Chief Medical Officer at AstraZeneca. He has also been appointed to the Olema Board of Directors. Dr. Bohen succeeds Cyrus Harmon, Ph.D., who had served as President and Chief Executive Officer of Olema since the company was founded. Dr. Harmon has assumed a newly created role of Chief Technology Officer.